MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Treatment"

  • MDS Virtual Congress 2020

    Implementation of computer game technologies for patients with ataxia due to post-traumatic head injury: Randomized controlled trial

    T. Voloshyn, V. Kozyavkin, O. Kachmar (Truskavets, Ukraine)

    Objective: Up to 85 % of patients with post-traumatic brain injury suffer motor discoordination, ataxia and dyspraxia. The formation of the correct movement patterns, improved…
  • MDS Virtual Congress 2020

    A translational approach to determine target concentrations of MIN-102 (leriglitazone) to support a Phase II study in Friedreich’s ataxia

    S. Poli, L. Rodríguez-Pascau, J. Ros, P. González-Cabo, E. Britti, D. Lynch, G. Pina, S. Pascual, M. Cerrada-Gimenez, D. Eckland, E. Traver, J. Wetering-de-Rooij, M. Martinell, U. Meya, P. Pizcueta (Gosselies, Belgium)

    Objective: To determine efficacious plasma concentration of leriglitazone from preclinical models of Friedreich´s ataxia (FRDA). To confirm CNS target engagement in a first-in human study.…
  • 2019 International Congress

    Effect of Speech therapy in the sleep of patients with Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3)

    G. Diaféria, JL. Pedroso, S. Park, F. Haddad, L. Haddad, L. Prado, G. Prado, O. Barsottini (São Paulo, Brazil)

    Objective: The objective of this study was to evaluate, through polysomnography, the effect of myofunctional therapy in patients with spinocerebellar ataxia type 3. Background: SCA3/MJD…
  • 2019 International Congress

    Reducing Ataxic Side Effects from VIM DBS Implantation in Essential Tremor: Advantages of Directional Stimulation

    D. Roque (Chapel Hill, NC, USA)

    Objective: To retrospectively evaluate effect of directional DBS stimulation on ataxia in an essential tremor patient population. Background: Essential tremor is the most common movement…
  • 2019 International Congress

    Opsoclonus-Myoclonus-Ataxia Syndrome – Ljubljana University Children’s Hospital clinical series

    J. Orazem Mrak, D. Osredkar, D. Neubauer (Ljubljana, Slovenia)

    Objective: Analysis of number, clinical characteristics and outcome of patients admitted to our department due to OMS in the past 25 years. Background: Opsoclonus-myoclonus-ataxia syndrome…
  • 2019 International Congress

    Supportive treatments for Ataxia, a Randomized Control Trial

    MIA. Arain (Jamshoro, Pakistan)

    Objective: The objective of this study is to evaluate the effectiveness of supporting treatments that improve awareness and the quality of patient life and counsel…
  • 2019 International Congress

    Exergame training in Early Onset Ataxia patients

    R. Brandsma, I. Ganzevoort, M. Berg, ZT. Dominguez Vega, LD. Jelsma, MM. Schoemaker, NM. Maurits, CJC. Lamoth, DA. Sival (Groningen, Netherlands)

    Objective: In ambulant EOA children, we aimed to study the effect of a medically designed “ice-skating exergame” on balance, posture and muscle force parameters Background:…
  • 2019 International Congress

    Phosphodiesterase inhibitors as a treatment for Friedreich’s ataxia

    J. González-Fernández, E. Zucchet, P. Calap-Quintana, P. González Cabo, MD. Moltó Ruiz (València, Spain)

    Objective: To evaluate the effect of phosphodiesterase inhibitors, as potential treatment for Friedreich’s ataxia, in a Drosophila melanogaster model of the disease. Background: Friedreich’s ataxia…
  • 2019 International Congress

    Normative Reference for Timed Up and Go Test (TUG) in Young Indian Adults- Preliminary Results

    D. Kaur, K. Umakant, T. Aziz, P. Jaiswal, M. Kumari, A. Gupta, G. Kumar (Patna, India)

    Objective: This study investigated the clinical usefulness of the time up and go test in young population and provide a reference range for healthy adults.…
  • 2019 International Congress

    Clinical and molecular features of a Chinese family with spinocerebellar ataxia type 6

    H. Luan, A. Liu (Yantai, China)

    Objective: To evaluate the clinical manifestation, CAG repeats of abnormal alleles, mitochondrial function and treatment of spinocerebellar ataxia type 6To evaluate the clinical manifestation, CAG…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley